Browsing by Author Kong, Xiangju

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2014Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor TherapyKefford, Richard (Rick); Long, Georgina; Chodon, Thinle; Dahlman, Kimberly; et al, Various; Guo, Rongqing; Hong, Aayoung; Hugo, Willy; Johnson, Douglas B; Kong, Xiangju; Koya, Richard; Moriceau, Gatien; Shi, Hubing; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreAcquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy, Cancer Discovery, vol.4, 1, 2014,pp 80-93
2012Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistanceKefford, Richard (Rick); Long, Georgina; Scolyer, Richard; Chodon, Thinle; Dahlman, Kimberly; Kong, Xiangju; Koya, Richard; Lee, H; Lee, Mi-Kyung; Lo, Roger; Moriceau, Gatien; Nelson, Stanley F.; Ng, Charles; Ribas, Antoni; Shi, Hubing; Sosman, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyMelanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance, Nature Communications, vol.3, 20122, 2012,pp 1-8
2014A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF InhibitionKefford, Richard (Rick); Long, Georgina; Scolyer, Richard; Chodon, Thinle; Hong, Aayoung; Hugo, Willy; Kong, Xiangju; Koya, Richard; Lo, Roger; Moriceau, Gatien; Ng, Charles; Ribas, Antoni; Shi, Hubing; Song, Chunying; Yu, Clarissa; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyA Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition, Cancer Discovery, vol.4, 1, 2014,pp 69-79
2012Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF InhibitorsKefford, Richard (Rick); Long, Georgina; Pupo, Gulietta; Bacchiocchi, Antonella; Chmielowski, Bartosz; Dahlman, Kimberly; Halaban, Ruth; Kong, Xiangju; Koya, Richard; Lo, Roger; Moriceau, Gatien; Nazarian, Ramin; Ribas, Antoni; Shi, Hubing; Sosman, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Medicine (Westmead)Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors, Cancer Discovery, vol.2, 5, 2012,pp 414-424